KYZATREX is an FDA-approved oral testosterone therapy designed to treat adult men with low or no testosterone due to certain medical conditions. This expansion provides men with a convenient, non-invasive option for testosterone replacement therapy (TRT) through Thrive’s accessible, patient-first healthcare model.
“We are always looking for ways to provide access to innovative health solutions and we are very excited to partner with KYZATREX,” said Colleen Hamilton, VP of Marketing at Thrive. “Our team believes everyone deserves to feel their best, and this partnership allows us to provide access to a safe, effective and painless TRT solution.”
Thrive is dedicated to making advanced medical treatments simple, affordable, and accessible, regardless of insurance coverage. Their approach includes holistic wellness support, expert guidance from board-certified doctors, and a seamless online process. As a trusted partner of O2 Fitness, Thrive extends its expertise to members looking to optimize their health, further reinforcing its reputation as a leader in comprehensive men’s health solutions.
"We are excited to see KYZATREX offered through Thrive, a company that shares our mission of providing men with effective, convenient treatment options,” said Amit Shah, COO of Marius Pharmaceuticals. “By expanding access to oral TRT, we are helping more men take control of their health in a way that fits seamlessly into their lifestyles."
About Marius Pharmaceuticals:
Marius Pharmaceuticals strives to better the lives of patients by focusing on therapies designed for hypogonadism or Testosterone Deficiency. The company's vision is to holistically improve metabolic health and mitigate significant unnecessary costs to the global healthcare system.
About Thrive:
Thrive believes that everyone deserves the opportunity to achieve optimal health and well-being. Thrive connects users with licensed medical providers for access to advanced medical weight loss solutions and Testosterone Replacement Therapy. The company's vision is to provide holistic wellness support beyond medication to help build a foundation for long-term success.
About KYZATREX® (testosterone undecanoate):
KYZATREX is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) and indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone. The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level (≤281 ng/dL) and at least one sign or symptom of testosterone deficiency. In the efficacy population (n=139), 88 percent of hypogonadal men treated with KYZATREX achieved a mean plasma total testosterone concentration (Cavg) over 24 hours within the normal range (222-800 ng/dL) on the final pharmacokinetic (PK) visit of the study at Day 90 (primary endpoint). Based on exploratory endpoints, patients who received KYZATREX reported improvements in symptoms of low testosterone, including quality of life, energy/fatigue, erectile function, sexual intercourse, and mood. The most common side effect reported in ≥2 percent of KYZATREX patients was increased blood pressure (2.6%). The safety and efficacy of KYZATREX in males less than 18 years old have not been established.
For more information please visit www.kyzatrex.com.
